194 related articles for article (PubMed ID: 4114813)
1. Lymphocyte transformation in immunoproliferative disorders.
Catovsky D; Holt PJ; Galton DA
Br J Cancer; 1972 Jun; 26(3):154-63. PubMed ID: 4114813
[TBL] [Abstract][Full Text] [Related]
2. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
Mantovani G; Petrini MT; Tognella S; Grifoni V
Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
[No Abstract] [Full Text] [Related]
3. Lymphocyte surface markers in lymphoproliferative disorders.
Aiuti F; Lacava V; Fiorilli M; Ciarla MV
Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
[No Abstract] [Full Text] [Related]
4. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
5. [Culture in vitro of lymphocytes in 14 cases of monoclonal paraproteinemia].
Blefari D; Gambertoglio G
Boll Soc Ital Biol Sper; 1969 May; 45(9):549-52. PubMed ID: 4099297
[No Abstract] [Full Text] [Related]
6. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
Ponzone A; Tarocco RP; Nicola P
Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
[No Abstract] [Full Text] [Related]
7. The human serum immunoglobulins.
Mattioli C; Tomasi TB
Dis Mon; 1970 Apr; ():1-35. PubMed ID: 4192345
[No Abstract] [Full Text] [Related]
8. [Immunological aspects of malignant lymphoproliferative diseases].
Rivero I; Diumenjo M
Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
[No Abstract] [Full Text] [Related]
9. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M
Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
[TBL] [Abstract][Full Text] [Related]
10. Membrane-bound IgD on human lymphoid cells, with special reference to immunodeficiency and immunoproliferative diseases.
Preud'Homme JL; Brouet JC; Seligmann M
Immunol Rev; 1977; 37():127-51. PubMed ID: 412774
[No Abstract] [Full Text] [Related]
11. Monoclonal immunoproliferative disorder of B-lymphocytes IgD/lambda changing from chronic lymphocytic leukaemia to myeloma and plasmacytic leukaemia pattern.
Buchi G; Palestro G; Leonardo E; Termine G; Autino R
Acta Haematol; 1982; 68(2):105-8. PubMed ID: 6812364
[TBL] [Abstract][Full Text] [Related]
12. [Blastic transformation of lymphocytes in culture stimulated by phytohemagglutinin (PHA) in hypoplastic anemia and lymphoproliferative diseases].
Samoĭlina NL; Polianskaia AM
Probl Gematol Pereliv Krovi; 1969 Oct; 14(10):3-13. PubMed ID: 4983365
[No Abstract] [Full Text] [Related]
13. [BIOLOGICAL, CYTOLOGICAL AND CLINICAL ASPECTS OF THE RELATIONS BETWEEN DISEASES CAUSED BY AUTOANTIBODIES AND PARAPROTEINEMIA].
QUATTRIN N
Riv Ist Sieroter Ital; 1964; 39():187-91. PubMed ID: 14183707
[No Abstract] [Full Text] [Related]
14. [T- and B-lymphocytes in lymphoproliferative diseases].
Tsveibakh AS; Gol'dman EI
Vopr Onkol; 1978; 24(1):11-6. PubMed ID: 305684
[TBL] [Abstract][Full Text] [Related]
15. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
Berceanu S; Gociu M
Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
[No Abstract] [Full Text] [Related]
16. [In vitro development of macrophages from PHA-stimulated blood cultures in Hodgkin's disease and in chronic lymphocytic leukaemia (author's transl)].
Navone R; Tosto M; Poggio E
Tumori; 1976; 62(1):19-24. PubMed ID: 1014113
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of IgM monoclonal gammopathy in 430 cases.
Kyle RA; Garton JP
Mayo Clin Proc; 1987 Aug; 62(8):719-31. PubMed ID: 3110508
[TBL] [Abstract][Full Text] [Related]
19. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
[TBL] [Abstract][Full Text] [Related]
20. [Immunopathology in lymphatic systemic diseases].
Huber H; Huber C; Michlmayr G
Verh Dtsch Ges Inn Med; 1973; 79():159-67. PubMed ID: 4133402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
